ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.77
-0.15%
US Tech 100
21,162.80
0.42%
S&P 500
6,083.57
0.36%
US Dollar vs CAD
1.43065
-0.01%
Bitcoin
97,674.32
1.14%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Serina Therapeutics Inc (SER) Share Price

Serina Therapeutics Inc

Serina Therapeutics Inc (SER)

Strategic Energy Resources Limited
4.60
0.00
(0.00%)
Closed February 06 3:00PM
Delayed by 15 minutes
4.60
0.00
(0.00%)
After Hours: 6:00PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
4.60
Bid
-
Ask
-
Volume
7,805
4.55 Day's Range 4.70
3.81 52 Week Range 19.93
Market Cap
40.903M
Previous Close
4.60
Open
4.62
Last Trade
100
@
4.6
Last Trade Time
Financial Volume
US$ 35,956
VWAP
4.6067
Average Volume (3m)
27,139
Shares Outstanding
8,891,976
Dividend Yield
-
PE Ratio
-2.76
Earnings Per Share (EPS)
-1.66
Revenue
142k
Net Profit
-14.8M

About Serina Therapeutics Inc

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging... AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
serinatherapeutics.com
Headquarters
Dover, Delaware, USA
Founded
-
Serina Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker SER. The last closing price for Serina Therapeutics was US$4.60. Over the last year, Serina Therapeutics shares have traded in a share price range of US$ 3.81 to US$ 19.93.

Serina Therapeutics currently has 8,891,976 shares outstanding. The market capitalization of Serina Therapeutics is US$40.90 million. Serina Therapeutics has a price to earnings ratio (PE ratio) of -2.76.

Ask ADVFN Intelligence (AI)

SER Latest News

More News

Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

HUNTSVILLE, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced the successful closing of the...

February 03 2025
GlobeNewswire Inc.

Form 8-K - Current report

February 03 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 03 2025
Edgar (US Regulatory)

Serina Therapeutics Announces Sale of UniverXome Subsidiary

- Transaction eliminates $11.2 million in debt, strengthening financial position - HUNTSVILLE, AL, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics Inc. (“Serina”) (NYSE American: SER), a...

January 15 2025
GlobeNewswire Inc.

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...

January 14 2025
GlobeNewswire Inc.

Form 8-K - Current report

January 06 2025
Edgar (US Regulatory)

Form 8-K - Current report

December 18 2024
Edgar (US Regulatory)

Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024

Meet with Serina’s CEO Steven A. LedgerParkinson's disease is a progressive neurological disorder that primarily affects movementContinuous dopaminergic stimulation (CDS) has been shown to reduce...

December 16 2024
GlobeNewswire Inc.

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit

HUNTSVILLE, AL, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...

December 11 2024
GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

December 09 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-1.498929336194.6754.6101414.74522829CS
4-0.22-4.56431535274.825.44.6182204.8095236CS
12-0.9-16.36363636365.56.8899994.15271395.1974111CS
26-3.6-43.90243902448.210.283.81207996.01793305CS
52-7.08-60.616438356211.6819.933.81188477.26036072CS
156-7.08-60.616438356211.6819.933.81188477.26036072CS
260-7.08-60.616438356211.6819.933.81188477.26036072CS

SER - Frequently Asked Questions (FAQ)

What is the current Serina Therapeutics share price?
The current share price of Serina Therapeutics is US$ 4.60
How many Serina Therapeutics shares are in issue?
Serina Therapeutics has 8,891,976 shares in issue
What is the market cap of Serina Therapeutics?
The market capitalisation of Serina Therapeutics is USD 40.9M
What is the 1 year trading range for Serina Therapeutics share price?
Serina Therapeutics has traded in the range of US$ 3.81 to US$ 19.93 during the past year
What is the PE ratio of Serina Therapeutics?
The price to earnings ratio of Serina Therapeutics is -2.76
What is the cash to sales ratio of Serina Therapeutics?
The cash to sales ratio of Serina Therapeutics is 287.5
What is the reporting currency for Serina Therapeutics?
Serina Therapeutics reports financial results in USD
What is the latest annual turnover for Serina Therapeutics?
The latest annual turnover of Serina Therapeutics is USD 142k
What is the latest annual profit for Serina Therapeutics?
The latest annual profit of Serina Therapeutics is USD -14.8M
What is the registered address of Serina Therapeutics?
The registered address for Serina Therapeutics is 108 LAKELAND AVE, KENT, DOVER, DELAWARE, 19901
What is the Serina Therapeutics website address?
The website address for Serina Therapeutics is serinatherapeutics.com
Which industry sector does Serina Therapeutics operate in?
Serina Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTMCastellum Inc
US$ 0.992
(29.96%)
13.83M
AZTRAzitra Inc
US$ 0.3837
(26.22%)
22.93M
TOPPToppoint Holdings Inc
US$ 2.15
(25.73%)
186.29k
DITAMCON Distributing Co
US$ 149.10
(15.72%)
3.4k
PTNPalatin Technologies Inc New
US$ 0.99995
(15.47%)
19.05M
EVXVanEck Environmental Services ETF
US$ 35.81
(-79.84%)
14.88k
SGNSigning Day Sports Inc
US$ 2.96
(-13.20%)
350.86k
AMBOAmbow Education Holding Ltd
US$ 2.53
(-11.23%)
11.47k
MYNDMynd ai Inc
US$ 1.115
(-10.80%)
62.72k
ATCHAtlasClear Holdings Inc
US$ 3.45
(-10.62%)
100.63k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.665
(2.11%)
70.69M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27.69
(-0.04%)
59.74M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 5.715
(-0.95%)
49.65M
ETHU2x Ether ETF
US$ 4.55
(-3.09%)
41.17M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3.07
(-5.54%)
39.98M

Discussion

View Full Feed
JJ8 JJ8 49 seconds ago
SOFI share price Descending Triple Bottom Breakdown on 6-Feb-2025. BLTA
SOFI
janice shell janice shell 1 minute ago
Sorry, crowin. I'm dead serious. Trump is the kind of hustler we've both followed through the pennies. He is no different at all.

I'm sorry you can't see that.
urge2surge urge2surge 1 minute ago
Will know at update. I think what most shareholders want is a ROI. At .0002, 320k buys up the entire outstanding. Lmao...
IDVV
4u2nv2 4u2nv2 2 minutes ago
You have been here watching this with us for a long time. Ben never paid or gave anyone restricted shares for ANYTHING. Much less 3.2 billion and that's controlling interest. Sounds to me like it's going to be one hell of a party.
MCIC
Mind_Sinker Mind_Sinker 2 minutes ago
I still have my REVO stocks.
skitahoe skitahoe 3 minutes ago
David, I don't believe the company is working on a buyout or partnerships at this time, not at these prices. I believe that LP previously has said that such things would be possible if NWBO was valued at a $20 billion or greater market caps, with our O/S that's around $15 or more a share. LP knows
NWBO
3331 3331 3 minutes ago
BIEL GONNA RUN LIKE 2021!
Scholars have always discussed the notion that history repeats itself.
https://microcapdaily.com/exciting-week-for-bioelectronics-corp-otcpink-biel/124825/
Termite7 Termite7 3 minutes ago
I'm trying for billionaire, but have no RMTD shares.......



I've got lot of poverty, though! I'd trade some of my poverty for RMTD shares if I could......



.......Thanks!!!
RMTD
mike_dotcom mike_dotcom 4 minutes ago
No anger, just tired of waiting. Every bit of so called progress is met with a declining stock price. And it never ends. Waiting for Godot. Godot never comes. Hope I didn't spoil the ending in case you've never read the book.
AVXL
RichardD1 RichardD1 4 minutes ago
Except they don’t claim over unity.
So what is your motivation to be here spreading what could meet the legal standards for defamation?
ASRE
dheminger dheminger 5 minutes ago
$ATWT balance sheets turn positive in last quarter of 2024. Revs exceeded 5M from less than 100k from previous year. Expecting 25M revs with current contractual obligations. 

Acquisition was mentioned in 10/24 with LOI hasn't been PR that it completed but sources show it completed in
ATWT
mypenneys mypenneys 5 minutes ago
I saw a bull elk in Yellowstone National park and it was light colored like the females. When I saw this one it was in velvet and it was very dark blackish brown. It was very different then the colors of the BULL ELK I seen in Yellowstone If it would’ve make an elk noise that would have confirme
COOP
crowin crowin 5 minutes ago
Good night Janice.. And sweet dreams about Trump and the USA
dheminger dheminger 5 minutes ago
$ATWT balance sheets turn positive in last quarter of 2024. Revs exceeded 5M from less than 100k from previous year. Expecting 25M revs with current contractual obligations. 

Acquisition was mentioned in 10/24 with LOI hasn't been PR that it completed but sources show it completed in
ATWT
fuagf fuagf 5 minutes ago
OOps, so sorry, screwed it again. It's this abominable new design. Must have had it on the wrong event. I pine for the days when the league view showed the four players of each Diehard member, names and all, right there clearly in front of us. Now we have a fallen, rotten tree.

Who
StayHumble StayHumble 5 minutes ago
GreenAcres acquisition launches✅$HCWC AnnualRevenue $75Million+💹 @healthiercmc
https://www.healthiercmc.com/news/2024/7/24/hcmc-announces-the-acquisition-of-greenacres-market-with-5-stores-located-in-kansas-and-oklahoma


https://static1.squarespace.com/sta
HCWC
Value_Investor Value_Investor 6 minutes ago
Correction: the Super Tiny OS is 5,261,641 shares (see the official link below), not 5,590,444 shares! So, each share of TNXP has $24.56 per share Huge Cash Value!

Since all the company debts were already paid off most recently, so its Huge Book Value is $34.82 per share!
TNXP
DrivenByPain DrivenByPain 6 minutes ago
Sue Xu Chairwoman SGD Holdings, Ltd. https://www.otcmarkets.com/stock/SGDH/profile
SGDH
dheminger dheminger 6 minutes ago
$ATWT balance sheets turn positive in last quarter of 2024. Revs exceeded 5M from less than 100k from previous year. Expecting 25M revs with current contractual obligations. 

Acquisition was mentioned in 10/24 with LOI hasn't been PR that it completed but sources show it completed in
ATWT
newmedman newmedman 6 minutes ago
Musk's Treasury Incursion Puts Entire Financial System at Risk

news-api.bloomberglaw.com/v1/resize-image?url=http%3A%2F%2Fbloomberg-bna-brightspot.s3.amazonaws.com%2Fb0%2F7d%2Fdd84934a476788e93ec035269247%2Felon-musk.jpg&width=1920&height=740&fit=cover&crop=4798x1849%2B0%2B0
El
janice shell janice shell 7 minutes ago
Just try and give him time to do so Janice!

He had four years to prove himself starting in 2017. He did a lousy job, and was not reelected. He then encouraged his crazy followers to invade the Capitol, and attack and injure dozens and dozens of cops. They also threatened to hang Mike
DrivenByPain DrivenByPain 7 minutes ago
Dr. Sue Xu Global Chairman of Citigroup Holdings https://www.kingdomnova.com/h-col-107.html
SGDH
dheminger dheminger 8 minutes ago
$ATWT balance sheets turn positive in last quarter of 2024. Revs exceeded 5M from less than 100k from previous year. Expecting 25M revs with current contractual obligations.

Acquisition was mentioned in 10/24 with LOI hasn't been PR that it completed but sources show it completed in 1
ATWT
branster branster 8 minutes ago
DavidW, I don’t know anything for certain but seen small bio’s get bought over and over again after approval, also partnerships was already mentioned in 10q, so again just basing on my experience and information I gather. Also, just makes sense with limited funds and man power NWBO has to run this t
NWBO
drugrunner drugrunner 9 minutes ago
What is your major concern here with a 27 cent stock 082??   

It's a penny stock that you seem to thin warrants you posting 10-20x says for months telling us how worthless the drug and company are!!! 

What would prompt you and the 25-50'other BASHERS who come here each
NWBO

Your Recent History

AMEX
SER
Serina Therapeutics
AQSE
STVG.GB
Stv
AQEU
NCABS
NCAB Group AB publ
LSE
ULE
Ultra Electronics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads